TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, cilt.17, ss.123-127, 2020 (ESCI İndekslerine Giren Dergi)
Objective: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer.